» Articles » PMID: 39294496

Spatial Transcriptomic Analysis of Primary and Metastatic Pancreatic Cancers Highlights Tumor Microenvironmental Heterogeneity

Abstract

Although the spatial, cellular and molecular landscapes of resected pancreatic ductal adenocarcinoma (PDAC) are well documented, the characteristics of its metastatic ecology remain elusive. By applying spatially resolved transcriptomics to matched primary and metastatic PDAC samples, we discovered a conserved continuum of fibrotic, metabolic and immunosuppressive spatial ecotypes across anatomical regions. We observed spatial tumor microenvironment heterogeneity spanning beyond that previously appreciated in PDAC. Through comparative analysis, we show that the spatial ecotypes exhibit distinct enrichment between primary and metastatic sites, implying adaptability to the local environment for survival and progression. The invasive border ecotype exhibits both pro-tumorigenic and anti-tumorigenic cell-type enrichment, suggesting a potential immunotherapy target. The ecotype heterogeneity across patients emphasizes the need to map individual patient landscapes to develop personalized treatment strategies. Collectively, our findings provide critical insights into metastatic PDAC biology and serve as a valuable resource for future therapeutic exploration and molecular investigations.

Citing Articles

Liver Metastasis in Cancer: Molecular Mechanisms and Management.

Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J MedComm (2020). 2025; 6(3):e70119.

PMID: 40027151 PMC: 11868442. DOI: 10.1002/mco2.70119.


Role of CD4 T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment.

An Q, Duan L, Wang Y, Wang F, Liu X, Liu C J Transl Med. 2025; 23(1):179.

PMID: 39953548 PMC: 11829416. DOI: 10.1186/s12967-025-06167-1.


Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy.

Li H, Zhang Z, Shi Z, Zhou S, Nie S, Yu Y Cell Rep Med. 2025; 6(2):101927.

PMID: 39914384 PMC: 11866503. DOI: 10.1016/j.xcrm.2024.101927.


Establishment and characterization of a sigmoid colon cancer organoid with spinal metastasis.

Chen J, Cheng S, Gu L, Huang Z, Zhang C, Sun C Front Cell Dev Biol. 2025; 12():1510264.

PMID: 39830210 PMC: 11739105. DOI: 10.3389/fcell.2024.1510264.

References
1.
Hosein A, Dougan S, Aguirre A, Maitra A . Translational advances in pancreatic ductal adenocarcinoma therapy. Nat Cancer. 2022; 3(3):272-286. DOI: 10.1038/s43018-022-00349-2. View

2.
Siegel R, Giaquinto A, Jemal A . Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1):12-49. DOI: 10.3322/caac.21820. View

3.
Houg D, Bijlsma M . The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma. Mol Cancer. 2018; 17(1):95. PMC: 6003100. DOI: 10.1186/s12943-018-0842-9. View

4.
Orth M, Metzger P, Gerum S, Mayerle J, Schneider G, Belka C . Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiat Oncol. 2019; 14(1):141. PMC: 6688256. DOI: 10.1186/s13014-019-1345-6. View

5.
Moffitt R, Marayati R, Flate E, Volmar K, Loeza S, Hoadley K . Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015; 47(10):1168-78. PMC: 4912058. DOI: 10.1038/ng.3398. View